Earnings Call · Q3 FY2022·2022-11-08

Q3 22EPS -57.38%·Rev n/aQ2 22EPS +35.62%·Rev n/aQ1 22EPS -53.85%·Rev n/aQ4 21EPS -11.11%·Rev n/a⚠ consensus missing

Coherus Oncology, Inc. CHRS

Marek Ciszewski — Senior Vice President

Denny Lanfear — Chief Executive Officer

McDavid Stilwell — Chief Financial Officer

Paul Reider — Executive

Theresa Lavallee — Executive

Rosh Dias — Executive

−12.3%1d on move date−10.2% vs SPY3d−2.5%5d−0.4%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CHRS calls or request research access.

More CHRS calls Browse calls Request research access